Sangamo Therapeutics Company

Sangamo Therapeutics is a genomic medicine company conducting research & development across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation.
Technology: Others
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Founded Date: 01.01.1995
Employees Number: 251-500
Funding Status: IPO
Total Funding: $74 M
Estimated Revenue: $10M to $50M

Visit Website
Register and Claim Ownership